These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27593227)

  • 21. Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction.
    Savvidou MD; Sotiriadis A; Kaihura C; Nicolaides KH; Sattar N
    Clin Sci (Lond); 2008 Oct; 115(7):219-24. PubMed ID: 18211260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does atenolol use during pregnancy cause small for gestational age neonates? A meta-analysis.
    Bratton S; Taylor MK; Cortez P; Schiattarella A; Fochesato C; Sisti G
    J Perinat Med; 2024 Oct; 52(8):858-862. PubMed ID: 39115600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Am J Cardiol; 2007 Aug; 100(4):690-6. PubMed ID: 17697830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective study of tadalafil for fetal growth restriction: Impact on maternal and perinatal outcomes.
    Kubo M; Umekawa T; Maekawa Y; Tanaka H; Nii M; Murabayashi N; Osato K; Kamimoto Y; Ikeda T
    J Obstet Gynaecol Res; 2017 Feb; 43(2):291-297. PubMed ID: 27987345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal subclinical vascular changes in fetal growth restriction with and without pre-eclampsia.
    Stergiotou I; Bijnens B; Cruz-Lemini M; Figueras F; Gratacos E; Crispi F
    Ultrasound Obstet Gynecol; 2015 Dec; 46(6):706-12. PubMed ID: 25678131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between cardiovascular function and fetal growth restriction in women with pre-eclampsia.
    Jia RZ; Liu XM; Wang X; Wu HQ
    Int J Gynaecol Obstet; 2010 Jul; 110(1):61-3. PubMed ID: 20362985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal cardiac function in fetal growth restriction.
    Bamfo JE; Kametas NA; Turan O; Khaw A; Nicolaides KH
    BJOG; 2006 Jul; 113(7):784-91. PubMed ID: 16827761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population.
    Bocchi EA; Böhm M; Borer JS; Ford I; Komajda M; Swedberg K; Tavazzi L;
    Cardiology; 2015; 131(4):218-24. PubMed ID: 25968495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction.
    Wareing M; Myers JE; O'Hara M; Baker PN
    J Clin Endocrinol Metab; 2005 May; 90(5):2550-5. PubMed ID: 15713717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of the causes of fetal growth restriction with unclear etiologies].
    Zhao J; Wu LF
    Zhonghua Fu Chan Ke Za Zhi; 2004 May; 39(5):329-33. PubMed ID: 15196417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
    Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
    J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-blockers increase the risk of being born small for gestational age or of being institutionalised during infancy.
    Xie RH; Guo Y; Krewski D; Mattison D; Walker MC; Nerenberg K; Wen SW
    BJOG; 2014 Aug; 121(9):1090-6. PubMed ID: 24628701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of maternal Doppler parameters of ophthalmic artery in fetuses with growth restriction in the third trimester of pregnancy: A case-control study.
    Melo NA; Araujo Júnior E; Helfer TM; Caetano AC; Zamarian AC; Moron AF; Diniz AL; Nardozza LM
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1330-6. PubMed ID: 26044926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
    Wikstrand J; Wedel H; Castagno D; McMurray JJ
    J Intern Med; 2014 Feb; 275(2):134-43. PubMed ID: 24118421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of pregnancies in women with Takayasu arteritis: complication of Takayasu arteritis involving obstetric or cardiovascular events.
    Tanaka H; Tanaka K; Kamiya C; Iwanaga N; Yoshimatsu J
    J Obstet Gynaecol Res; 2014 Sep; 40(9):2031-6. PubMed ID: 25181623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective cohort study about the lymphocyte subpopulations' change and impact on the pregnancy outcome in fetal growth restriction.
    Xiong F; Tong Y; You Y; Li P; Huo T; Tu W; Mao M
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2773-7. PubMed ID: 22862299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Placental vascular lesion differences in pregnancy-induced hypertension and normotensive fetal growth restriction.
    Kovo M; Schreiber L; Ben-Haroush A; Wand S; Golan A; Bar J
    Am J Obstet Gynecol; 2010 Jun; 202(6):561.e1-5. PubMed ID: 20223448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal and neonatal outcomes in labor and at delivery when long QT syndrome is present.
    Tanaka H; Katsuragi S; Tanaka K; Sawada M; Iwanaga N; Yoshimatsu J; Ikeda T
    J Matern Fetal Neonatal Med; 2016; 29(7):1117-9. PubMed ID: 25902397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.